World In Vitro Diagnostic Technologies Market


USD 2,450.00

* Required Fields

USD 2,450.00


Be the first to review this product

The World In Vitro Diagnostics Technology Market report summarizes the market and conditions affecting the market. Covering dynamic and emerging subsegments, the report offers a comprehensive view of the World's IVD market over the next seven years. It provides analyses of revenues, drivers, restraints and challenges affecting the market and its future. Technology and market trends, as well as regulatory issues are addressed. The base year for this report is 2000 and projections are forecasted to 2007.

Table of Contents

World In Vitro Diagnostic Technologies Market, Executive SummaryExecutive SummaryExecutive SummaryWorld In Vitro Diagnostic Technologies Market, Total MarketMarket Overview: DefinitionsIntroductionMarket Engineering AnalysisResearch MethodologyMarket Drivers Restraints and TrendsMarket DriversMarket RestraintsMarket and Technology TrendsCompetitive Structure and Revenue ForecastsCompetitive StructureRevenue Forecast OverviewRevenue Forecast AnalysisChallenges Strategies and AwardsChallengesStrategiesMarket Engineering Leadership Award: Roche DiagnosticsMergers & Acquisitions Award: Roche DiagnosticsProduct Quality Leadership Award: Bayer DiagnosticsProduct Innovation Award: LifeScan (Johnson & Johnson)Strategic Alliance Innovation Award: Abbott DiagnosticsWorld In Vitro Diagnostic Technologies Market, U.S.OverviewIntroductionTotal MarketU.S. MarketWorld In Vitro Diagnostic Technologies Market, Western EuropeOverviewIntroductionTotal MarketWestern Europe MarketWorld In Vitro Diagnostic Technologies Market, JapanOverviewIntroductionTotal MarketJapan MarketWorld In Vitro Diagnostic Technologies Market, Rest Of WorldOverviewIntroductionTotal MarketRest of World MarketWorld In Vitro Diagnostic Technologies Market, Decision Support DatabaseCausal FactorsPrevalence of DiabetesPercent Prevalence of DiabetesPrevalence of HIV PopulationIncidence of TuberculosisIncidence of Tuberculosis Per 1000 PopulationIncidence of Colorectal CancerIncidence of Liver CancerIncidence of Prostrate CancerDemography and Healthcare InfrastructurePopulation Over 65 Years of AgeNumber of HospitalsNumber of Specialized Medical PractitionersNumber of Physicians

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.